These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 7851581

  • 1. Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment.
    Fernández-Montolí ME, Díez-Gibert O, Samaniego JM, Balagueró L, Navarro MA.
    Fertil Steril; 1995 Mar; 63(3):522-7. PubMed ID: 7851581
    [Abstract] [Full Text] [Related]

  • 2. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA, Kettel LM, Morales AJ, Roberts VJ, Yen SS.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [Abstract] [Full Text] [Related]

  • 3. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
    Vollenhoven BJ, Pearce P, Herington AC, Healy DL.
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
    [Abstract] [Full Text] [Related]

  • 4. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.
    Rein MS, Friedman AJ, Stuart JM, MacLaughlin DT.
    Fertil Steril; 1990 Jun; 53(6):1018-23. PubMed ID: 2112489
    [Abstract] [Full Text] [Related]

  • 5. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment.
    Englund K, Blanck A, Gustavsson I, Lundkvist U, Sjöblom P, Norgren A, Lindblom B.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4092-6. PubMed ID: 9814497
    [Abstract] [Full Text] [Related]

  • 6. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.
    van de Ven J, Sprong M, Donker GH, Thijssen JH, Mak-Kregar S, Blankenstein MA.
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():61-8. PubMed ID: 12227888
    [Abstract] [Full Text] [Related]

  • 7. Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase.
    Healy DL, Lawson SR, Abbott M, Baird DT, Fraser HM.
    J Clin Endocrinol Metab; 1986 Sep; 63(3):619-25. PubMed ID: 3090092
    [Abstract] [Full Text] [Related]

  • 8. The binding of steroids to myometrium and leiomyomata (fibroids) in women treated with the gonadotrophin-releasing hormone agonist Zoladex (ICI 118630).
    Lumsden MA, West CP, Hawkins RA, Bramley TA, Rumgay L, Baird DT.
    J Endocrinol; 1989 May; 121(2):389-96. PubMed ID: 2526844
    [Abstract] [Full Text] [Related]

  • 9. Treatment of uterine leiomyomas in perimenopausal women with gonadotropin-releasing hormone agonists.
    Nakamura Y, Yoshimura Y.
    Clin Obstet Gynecol; 1993 Sep; 36(3):660-7. PubMed ID: 8403612
    [No Abstract] [Full Text] [Related]

  • 10. Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy.
    Nisolle M, Gillerot S, Casanas-Roux F, Squifflet J, Berliere M, Donnez J.
    Hum Reprod; 1999 Nov; 14(11):2844-50. PubMed ID: 10548634
    [Abstract] [Full Text] [Related]

  • 11. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A, Milkov V.
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [Abstract] [Full Text] [Related]

  • 12. Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study.
    Maheux R, Guilloteau C, Lemay A, Bastide A, Fazekas AT.
    Am J Obstet Gynecol; 1985 Aug 15; 152(8):1034-8. PubMed ID: 3927734
    [Abstract] [Full Text] [Related]

  • 13. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
    Spona J, Ulm R, Bieglmayer C, Husslein P.
    Gynecol Obstet Invest; 1979 Aug 15; 10(2-3):71-80. PubMed ID: 535775
    [Abstract] [Full Text] [Related]

  • 14. Endocrine profile associated with estrogen and progesterone receptors in leiomyoma and normal myometrium.
    Sadan O, van Iddekinge B, Savage N, van der Walt LA, Zakut H.
    Gynecol Endocrinol; 1990 Mar 15; 4(1):33-42. PubMed ID: 2110713
    [Abstract] [Full Text] [Related]

  • 15. A randomized, placebo-controlled, dose-ranging trial comparing fulvestrant with goserelin in premenopausal patients with uterine fibroids awaiting hysterectomy.
    Donnez J, Hervais Vivancos B, Kudela M, Audebert A, Jadoul P.
    Fertil Steril; 2003 Jun 15; 79(6):1380-9. PubMed ID: 12798886
    [Abstract] [Full Text] [Related]

  • 16. Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography.
    Donnez J, Schrurs B, Gillerot S, Sandow J, Clerckx F.
    Fertil Steril; 1989 Jun 15; 51(6):947-50. PubMed ID: 2498131
    [Abstract] [Full Text] [Related]

  • 17. Luteinizing hormone-releasing hormone analog therapy of uterine fibroid: analysis of results obtained with buserelin administered intranasally and goserelin administered subcutaneously as a monthly depot.
    Costantini S, Anserini P, Valenzano M, Remorgida V, Venturini PL, De Cecco L.
    Eur J Obstet Gynecol Reprod Biol; 1990 Oct 15; 37(1):63-9. PubMed ID: 2142921
    [Abstract] [Full Text] [Related]

  • 18. Changes in proliferating and apoptotic markers of leiomyoma following treatment with a selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
    Yun BS, Seong SJ, Cha DH, Kim JY, Kim ML, Shim JY, Park JE.
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug 15; 191():62-7. PubMed ID: 26093349
    [Abstract] [Full Text] [Related]

  • 19. [GnRH-analogs in the therapy of uterine myomatosis].
    Wieacker P, Geisthövel F, Adelberger V, Breckwoldt M.
    Ther Umsch; 1990 Dec 15; 47(12):951-7. PubMed ID: 2151405
    [Abstract] [Full Text] [Related]

  • 20. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A, Vollenhoven B, Sowter M.
    Cochrane Database Syst Rev; 2001 Dec 15; (2):CD000547. PubMed ID: 11405968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.